15.07.2013
- Buying Alexion Pharmaceuticals would help Roche make a splash in the newly lucrative area of rare or so-called orphan diseases, but it could command a price that the Swiss...
11.07.2013
- As activist investors launch more high profile corporate battles in the United States, in Europe they are eschewing public hectoring for private talks. Aggressive activism has had...
10.07.2013
- GlaxoSmithKline plans to exploit new technology from private British biotech company Immunocore to develop next-generation drugs against cancer that fight tumors in ways antibody...
03.07.2013
- Turkish generic drug maker Sanovel has been put up for sale by parent Toksoz Holding and could fetch between $500 million and $1 billion, three sources close to the matter told...
02.07.2013
- Onyx Pharmaceuticals, whose cancer drugs promise a strong revenue stream, is attracting preliminary buyout interest from several large pharmaceutical companies such as Pfizer and...
01.07.2013
- Cancer drugmaker Onyx Pharmaceuticals said on Sunday it rejected a roughly $10 billion takeover offer from larger biotechnology company Amgen as too low but still is considering...
01.07.2013
- Monsanto's unapproved, experimental genetically engineered wheat, which is feared to have potentially contaminated U.S. wheat supplies after it was found growing in an Oregon field...
01.07.2013
- European regulators have cleared the way for the first serious threat to the makers of multibillion-dollar biotechnology drugs to treat diseases such as cancer and rheumatoid...
20.06.2013
- An executive with Monsanto and two other pioneers in agricultural biotechnology said their selection as winners of the $250,000 World Food Prize on Wednesday should encourage the...
19.06.2013
- Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research and boosting acquisitions set to take up to four years to pay off, its chief...
